Klaus Kirchfeld

Title: Klaus Kirchfeld: Innovator in Biochemistry

Introduction

Klaus Kirchfeld is a notable inventor based in Petershausen, Germany. He has made significant contributions to the field of biochemistry, particularly through his innovative work on tear lipocalin muteins. With a total of four patents to his name, Kirchfeld's inventions are paving the way for advancements in medical science.

Latest Patents

One of his latest patents focuses on tear lipocalin muteins that bind to the IL-4 receptor alpha. This invention relates to novel muteins derived from human tear lipocalin, which exhibit specific binding capabilities. The sequences of these muteins comprise particular combinations of amino acids, with mutated residues present at various sequence positions. Additionally, the invention includes a corresponding nucleic acid molecule encoding such a mutein and a method for producing both the mutein and its encoding nucleic acid molecule.

Career Highlights

Klaus Kirchfeld has worked with prominent companies in the pharmaceutical industry, including Pieris Pharmaceuticals GmbH and AstraZeneca AB. His experience in these organizations has contributed to his expertise and innovative capabilities in biochemistry.

Collaborations

Some of his notable coworkers include Andreas Hohlbaum and Alexandra Baehre. Their collaborative efforts have likely played a role in advancing the research and development of his inventions.

Conclusion

Klaus Kirchfeld's work in the field of biochemistry, particularly with tear lipocalin muteins, showcases his innovative spirit and dedication to scientific advancement. His contributions are significant in the ongoing exploration of medical applications.